The global regulatory landscape is growing and increasingly divergent, challenging banks that lack automated and optimized regulatory reporting processes. To tackle the complexity and costs, robust ...

The process of conducting ongoing restricted party (or denied party) screening is a critical component of the UAB Export Control Compliance Program. Such screening processes help to determine whether ...

Obtaining FDA clearance or approval is just the beginning of a company’s regulatory journey. As FDA-regulated products evolve, changes to software, labeling, manufacturing processes, and design are a ...